Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty
Fluoxetine and sertraline reduce height gain and IGF-1 concentration, in a dose-dependent manner. Longer-term studies are necessary.
Authors
- Griselda Barba-Villalobos
- Sridevi Devaraj (ORCID: https://orcid.org/0000-0001-9189-7914)
- Stephanie Dinh
- José M. Garcia (ORCID: https://orcid.org/0000-0002-4245-1753)
- Fida Bacha (ORCID: https://orcid.org/0000-0002-9942-1889)
- Stephanie Sisley (ORCID: https://orcid.org/0000-0003-2900-7014)
- Babette S. Zemel (ORCID: https://orcid.org/0000-0002-6164-7348)
- James A. Mills (ORCID: https://orcid.org/0000-0002-3101-7249)
- Chadi A. Calarge (ORCID: https://orcid.org/0000-0002-4368-1294)
- Chima Amushie
- Jacqueline Nguyen
Institutions
- University of Iowa (US)
- University of Puget Sound (US)
- Baylor College of Medicine (US)
- University of Washington (US)
- Geriatric Research Education and Clinical Center (US)
- ORCID (US)
- University of Pennsylvania (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Journal of Clinical Psychopharmacology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1097/jcp.0000000000001922
- Citations
- 1
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.36